Impressive Ad campaign – for Gilenya (by Novartis)

Gilenya logoGILENYA® was the first pill proven to treat relapsing forms of Multiple Sclerosis (MS)

Company : Novartis

Campaign : “HEY MS, Take This.”

The ad campaign is designed to promote Gilenya for MS treatment

Creative Agency: Draftfcb Healthcare (FCB Health – New York)

Draftfcb Healthcare created patient-centered ‘HEY MS, Take This’ campaign’


Campaign: Bold and empowering.

  • As a healthcare campaign, the print ad and web video (above) used a bold tone, colorful language and visuals which are unique to traditional pharma ads.
  • The campaign includes an online community for patients to share the personal struggles and experiences with MS, also how the drug has made their life engaging with daily routine works.
  • In addition, first time a pharma brand engaged an extensive suite of social media channels which includes TwitterFacebook and YouTube to empower the community of MS patients

Speak up and share your message Platform – A community for Patients to share their stories


The campaign is inspired by an shelling of stories about the positive impact Gilenya has had on the lives of patients.

  • Gilenya is the first oral disease modifying therapy for people living with relapsing forms of Multiple Sclerosis (MS).
  • Prior to this revolutionary pill, the only treatment options patients had required regular injections or infusions.


Watch this video to understand the creative evolution: 🙂 🙂 🙂


Like and Share :

1 responses on "Impressive Ad campaign – for Gilenya (by Novartis)"

  1. Great and empowering, FCB is amazing company

Leave a Message

Your email address will not be published. Required fields are marked *


Join fastest growing subscribers who benefit from PharmaCrunch’s coverage on "Pharmaceuticals - Must to Know" updates

Testimonial from Subscribers

Read more

Nirbhay Patel

Business Manager - Sanofi India
2016 © PharmaCrunch All rights reserved
Skip to toolbar